Mitochondrial Disorders Due to Nuclear OXPHOS Gene Defects

  • Cristina Ugalde
  • María Morán
  • Alberto Blázquez
  • Joaquín Arenas
  • Miguel A. Martín
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 652)


Because of the bi-genomic origin of the OXPHOS system, mitochondrial disease-associated mutations have been found in both mtDNA and nuclear structural genes. In the last years, interest has shifted toward mendelian genetics in mitochondrial disease, not only because the majority of the OXPHOS system subunits are encoded by the nuclear genome, but also because a large number of yet unknown nuclear proteins, such as regulatory proteins and assembly factors, are likely involved in its biogenesis and function. A clinical-genetic classification can be proposed for nuclear defects that affect the biogenesis of the OXPHOS system, as follows: (i) disorders due to nuclear gene defects encoding structural components or assembly factors of the OXPHOS complexes, (ii) disorders due to gene defects in the biogenesis of protein constituents of the OXPHOS system, (iii) disorders due to defects in the biosynthesis of non-protein constituents of the respiratory chain, and (iv) disorders due to gene defects encoding proteins involved in mitochondrial dynamics.


Mitochondrial biogenesis, Mitochondrial respiratory chain, Nuclear gene defect, OXPHOS disorders, Respiratory subunits assembly 


  1. 1.
    Agostino A, Invernizzi F, Tiveron C, Fagiolari G, Prelle A, Lamantea E, Giavazzi A, Battaglia G, Tatangelo L, Tiranti V, Zeviani M (2003). Constitutive knockout of Surf1 is associated with high embryonic lethality, mitochondrial disease and cytochrome c oxidase deficiency in mice. Hum Mol Genet 12:399–413.PubMedGoogle Scholar
  2. 2.
    Agsteribbe E, Huckriede A., Veenhuis M, Ruiters MH, Niezen-Koning KE, Skjeldal OH, Skullerud K, Gupta RS, Hallberg R, van Diggelen OP (1993). A fatal, systemic mitochondrial disease with decreased mitochondrial enzyme activities, abnormal ultrastructure of the mitochondria and deficiency of heat shock protein 60. Biochem Biophys Res Commun 193:146–154.PubMedGoogle Scholar
  3. 3.
    Allikmets R, Raskind WH, Hutchinson A, Schueck ND, Dean M, Koeller DM (1999). Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Molec Genet 8:743–749.PubMedGoogle Scholar
  4. 4.
    Amati-Bonneau P, Guichet A, Olichon A, Chevrollier A, Viala F, Miot S, Ayuso C, Odent S, Arrouet C, Verny C, Calmels M-N, Simard G, Belenguer P, Wang J, Puel J-L, Hamel C, Malthiery Y, Bonneau D, Lenaers G, Reynier P (2005). OPA1 R445H mutation in optic atrophy associated with sensorineural deafness. Ann Neurol 58:958–963.PubMedGoogle Scholar
  5. 5.
    Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissière A, Campos Y, Rivera H, de la Aleja JG, Carroccia R, Iommarini L, Labauge P, Figarella-Branger D, Marcorelles P, Furby A, Beauvais K, Letournel F, Liguori R, La Morgia C, Montagna P, Liguori M, Zanna C, Rugolo M, Cossarizza A, Wissinger B, Verny C, Schwarzenbacher R, Martín MA, Arenas J, Ayuso C, Garesse R, Lenaers G, Bonneau D, Carelli V (2008). OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus’ phenotypes. Brain 131:338–351.PubMedGoogle Scholar
  6. 6.
    Andreu AL, Hanna MG, Reichmann H, Bruno C, Penn, AS, Tanji K, Pallotti F, Iwata S, Bonilla E, Lach B, Morgan-Hughes J, DiMauro S (1999). Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med 341:1037–1044.PubMedGoogle Scholar
  7. 7.
    Antonicka H, Ogilvie I, Taivassalo T, Anitori RP, Haller RG, Vissing J, Kennaway NG, Shoubridge EA (2003). Identification and characterization of a common set of complex I assembly intermediates in mitochondria from patients with complex I deficiency. J Biol Chem 278:43081–43088.PubMedGoogle Scholar
  8. 8.
    Antonicka H, Leary SC, Guercin GH, Agar, Horvath R, Kennaway NG, Harding CO, Jaksch M, Shoubridge EA (2003). Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency. Hum Mol Genet 12:2693–2702.PubMedGoogle Scholar
  9. 9.
    Antonicka H, Mattman A, Carlson CG, Glerum DM, Hoffbuhr KC, Leary SC, Kennaway NG, Shoubridge EA (2003). Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy. Am J Hum Genet 72:101–114.PubMedGoogle Scholar
  10. 10.
    Antonicka H, Sasarman F, Kennaway NG, Shoubridge EA (2006). The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1. Hum Mol Genet 15:1835–1846.PubMedGoogle Scholar
  11. 11.
    Arnold S, Kadenbach B (1997). Cell respiration is controlled by ATP, an allosteric inhibitor of cytochrome-c oxidase. Eur J Biochem 249:350–354.PubMedGoogle Scholar
  12. 12.
    Astuti D, Latif F, Dallol A, Dahia PLM, Douglas F, George E, Skoldberg F, Husebye ES, Eng C, Maher ER (2001). Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69:49–54.PubMedGoogle Scholar
  13. 13.
    Astuti D, Morris M, Krona C, Abel F, Gentle D, Martinsson T, Kogner P, Neumann HP, Voutilainen R, Eng C, Rustin P, Latif F, Maher ER (2004). Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma. Br J Cancer 91:1835–1841.PubMedGoogle Scholar
  14. 14.
    Auré K, Benoist JF, Ogier de Baulny H, Romero NB, Rigal O, Lombès A (2004). Progression despite replacement of a myopathic form of coenzyme Q10 defect. Neurology 63:727–729.PubMedGoogle Scholar
  15. 15.
    Babady NE, Carelle N, Wells RD, Rouault TA, Hirano M, Lynch DR, Delatycki MB, Wilson RB, Isaya G, Puccio H (2007). Advancements in the pathophysiology of Friedreich’s Ataxia and new prospects for treatments. Mol Genet Metab 92:23–35.PubMedGoogle Scholar
  16. 16.
    Baden KN, Murray J, Capaldi RA, Guillemin K (2007). Early developmental pathology due to cytochrome c oxidase deficiency is revealed by a new zebrafish model. J Biol Chem 282:34839–34849.PubMedGoogle Scholar
  17. 17.
    Barel O, Shorer Z, Flusser H, Ofir R, Narkis G, Finer G, Shalev H, Nasasra A, Saada A, Birk OS (2008). Mitochondrial complex III deficiency associated with a homozygous mutation in UQCRQ. Am J Hum Genet 82:1211–1216.PubMedGoogle Scholar
  18. 18.
    Barghuti F, Elian K, Gomori JM, Shaag A, Edvardson S, Saada A, Elpeleg O (2008). The unique neuroradiology of complex I deficiency due to NDUFA12L defect. Mol Genet Metab. 94:78–82.PubMedGoogle Scholar
  19. 19.
    Baum H, Rieske JS, Silman HI, Lipton SH (1967). On the mechanism of electron transfer in complex III of the electron transfer chain. Proc Natl Acad Sci U S A 57:798–805.PubMedGoogle Scholar
  20. 20.
    Barros MH, Carlson CG, Glerum DM, Tzagaloff A (2001). Involvement of mitochondrial ferredoxin and Cox15p in hydroxylation of heme O. FEBS Lett 492:133–138.PubMedGoogle Scholar
  21. 21.
    Barros MH, Nobrega FG, Tzagoloff A (2002). Mitochondrial ferredoxin is required for heme A synthesys in Saccharomyces cervisiae. J Biol chem. 277:9997–10002.PubMedGoogle Scholar
  22. 22.
    Barros MH, Tzagoloff A (2002). regulation of heme A biosynthetic pathway in Saccharomyces cerevisiae. FEBS Lett 516: 119–123.Google Scholar
  23. 23.
    Barth PG, Valianpour F, Bowen VM, Lam J, Duran M, Vaz FM, Wanders RJ (2004). X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am J Med Genet A 126A:349–354.PubMedGoogle Scholar
  24. 24.
    Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der May A, Taschner PEM, Rubinstein WS, Myers EN, Richard CWIII, Cornelisse CJ, Devilee P, Devlin B (2000). Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848–851.PubMedGoogle Scholar
  25. 25.
    Bekri S, Kispal G, Lange H, Fitzsimons E, Tolmie J, Lill R, Bishop DF (2000). Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation. Blood 96:3256–3264.PubMedGoogle Scholar
  26. 26.
    Bencze KZ, Kondapalli KC, Cook JD, McMahon S, Millán-Pacheco C, Pastor N, Stemmler TL (2006). The structure and function of frataxin. Crit Rev Biochem Mol Biol 41:269–291.PubMedGoogle Scholar
  27. 27.
    Benit P, Chretien D, Kadhom N, De Lonlay-Debeney P, Cormier-Daire V, Cabral A, Peudenier S, Rustin P, Munnich A, Rotig A (2001). Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. Am J Hum Genet 68:1344–1352.PubMedGoogle Scholar
  28. 28.
    Benit P, Steffann J, Lebon S, Chretien D, Kadhom N, de Lonlay P, Goldenberg A, Dumez Y, Dommergues M, Rustin P, Munnich A, Rotig A (2003). Genotyping microsatellite DNA markers at putative disease loci in inbred/multiplex families with respiratory chain complex I deficiency allows rapid identification of a novel nonsense mutation (IVS1nt -1) in the NDUFS4 gene in Leigh syndrome. Hum Genet 112:563–566.PubMedGoogle Scholar
  29. 29.
    Benit P, Beugnot R, Chretien D, Giurgea I, De Lonlay-Debeney P, Issartel JP, Corral-Debrinski M, Kerscher S, Rustin P, Rotig A, Munnich A (2003). Mutant NDUFV2 subunit of mitochondrial complex I causes early onset hypertrophic cardiomyopathy and encephalopathy. Hum Mutat 21:582–586.PubMedGoogle Scholar
  30. 30.
    Benit P, Slama A, Cartault F, Giurgea I, Chretien D, Lebon S, Marsac C, Munnich A, Rotig A, Rustin P (2004). Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome. J Med Genet 41:14–17.PubMedGoogle Scholar
  31. 31.
    Berger I, Hershkovitz E, Shaag A, Edvardson S, Saada A, Elpeleg O (2008). Mitochondrial complex I deficiency caused by a deleterious NDUFA11 mutation. Ann Neurol 63:405–408.PubMedGoogle Scholar
  32. 32.
    Bione S, D’Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D (1996). A novel X-linked gene, G4.5. (sic) is responsible for Barth syndrome. Nature Genet 12:385–389.PubMedGoogle Scholar
  33. 33.
    Birch-Machin MA, Taylor RW, Cochran B, Ackrell BA, Turnbull DM (2000). Late-onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene. Ann Neurol 48:330–335.PubMedGoogle Scholar
  34. 34.
    Boitier E, Degoul F, Desguerre I, Charpentier C, François D, Ponsot G, Diry M, Rustin P, Marsac C (1998). A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency. J Neurol Sci 156:41–46.PubMedGoogle Scholar
  35. 35.
    Borisov VB (2002). Defects in mitochondrial respiratory complexes III and IV, and human pathologies. Mol Aspects Med 23:385–412.PubMedGoogle Scholar
  36. 36.
    Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Péquignot E, Munnich A, Rötig A (1995). Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 11:144–149.PubMedGoogle Scholar
  37. 37.
    Briones P, Vilaseca MA, Ribes A, Vernet A, Lluch M, Cusi V, Huckriede A, Agsteribbe E (1997). A new case of multiple mitochondrial enzyme deficiencies with decreased amount of heat shock protein 60. J Inherit Metab Dis 20:569–577.PubMedGoogle Scholar
  38. 38.
    Budde SMS, van den Heuvel LPWJ, Janssen AJ, Smeets RJP, Buskens CAF, DeMeirleir L, Van Coster R, Baethmann M, Voit T, Trijbels JMF, Smeitink JAM (2000). Combined enzymatic complex I and III deficiency associated with mutations in the nuclear encoded NDUFS4 gene. Biochem Biophys Res Commun 275:63–68.PubMedGoogle Scholar
  39. 39.
    Bugiani M, Invernizzi F, Alberio S, Briem E, Lamantea E, Carrara F, Moroni I, Farina L, Spada M, Donati MA, Uziel G, Zeviani M (2004). Clinical and molecular findings in children with complex I deficiency. Biochim Biophys Acta 1659:136–147.PubMedGoogle Scholar
  40. 40.
    Bugiani M, Tiranti V, Farina L, Uziel G, Zeviani M (2005). Novel mutations in COX15 in a long surviving Leigh syndrome patient with cytochrome c oxidase deficiency. J Med Genet 42:e28.PubMedGoogle Scholar
  41. 41.
    Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N (2004). Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74:1303–1308.PubMedGoogle Scholar
  42. 42.
    Camaschella C (2008). Recent advances in the understanding of inherited sideroblastic anaemia. Br J Hematol 143:27–38.Google Scholar
  43. 43.
    Camaschella C, Campanella A, De Falco L, Boschetto L, Merlini R, Silvestri L, Levi S, Iolascon A (2007). The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood 110: 1353–1358.PubMedGoogle Scholar
  44. 44.
    Carelli V, La Morgia C, Iommarini L, Carroccia R, Mattiazzi M, Sangiorgi S, Farne’ S, Maresca A, Foscarini B, Lanzi L, Amadori M, Bellan M, Valentino ML (2007). Mitochondrial optic neuropathies: how two genomes may kill the same cell type? Biosci Rep 27:173–184.PubMedGoogle Scholar
  45. 45.
    Carroll J, Fearnley IM, Shannon RJ, Hirst J, Walker JE (2003). Analysis of the subunit composition of complex I from bovine heart mitochondria. Mol Cell Proteomics 2:117–126.PubMedGoogle Scholar
  46. 46.
    Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, Fernandez P, De Michele G, Filla A, Cocozza S, Marconi R, Dürr A, Fontaine B, Ballabio A (1998). Spastic paraplegia and OXPHOS impairmentcaused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93:973–983.PubMedGoogle Scholar
  47. 47.
    Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC (2003). Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160:189–200.PubMedGoogle Scholar
  48. 48.
    Chen H, Chan DC (2004). Mitochondrial dynamics in mammals. Curr Top Dev Biol 59:119–144PubMedGoogle Scholar
  49. 49.
    Chomyn A, Patel SD, Cleeter MW, Ragan CI, Attardi G (1988). The site of synthesis of the iron-sulfur subunits of the flavoprotein and iron-protein fractions of human NADH dehydrogenase. J Biol Chem 263:16395–16400.PubMedGoogle Scholar
  50. 50.
    Cipolat S, Martins de Brito O, Dal Zilio B, Scorrano L (2004). OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc Natl Acad Sci U S A 101:15927–15932.PubMedGoogle Scholar
  51. 51.
    Coenen MJ, van den Heuvel LP, Ugalde C, Ten Brinke M, Nijtmans LG, Trijbels FJ, Beblo S, Maier EM, Muntau AC, Smeitink JA (2004). Cytochrome c oxidase biogenesis in a patient with a mutation in COX10 gene. Ann Neurol 56: 560–564.PubMedGoogle Scholar
  52. 52.
    Coenen MJ, Antonicka H, Ugalde C, Sasarman F, Rossi R, Heister JG, Newbold RF, Trijbels FJ, van den Heuvel LP, Shoubridge EA, Smeitink JA (2004). Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. N Engl J Med 351:2080–2086.PubMedGoogle Scholar
  53. 53.
    Cruciat CM, Hell K, Folsch H, Neupert W, Stuart RA (1999). Bcs1p, an AAA-family member, is a chaperone for the assembly of the cytochrome bc(1) complex. EMBO J 18:5226–5233.PubMedGoogle Scholar
  54. 54.
    Davey KM, Parboosingh JS, McLeod DR, Chan A, Casey R, Ferreira P, Snyder FF, Bridge PJ, Bernier FP (2006). Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-like condition. J Med Genet 43:385–393.PubMedGoogle Scholar
  55. 55.
    Delatycki MB, Williamson R, Forrest SM (2000). Friedreich ataxia: an overview. J Med Genet 37:1–8.PubMedGoogle Scholar
  56. 56.
    Dell’agnello C, Leo S, Agostino A, Szabadkai G, Tiveron C, Zulian a, Prelle A, Roubertoux P, Rizzuto R, Zeviani M (2007). Increased longevity and refractoriness to Ca2+-dependent neurodegeneration in Surf1 knockout mice. Hum Mol Genet 16:431–444.PubMedGoogle Scholar
  57. 57.
    Delettre C, Lenaers G, Griffoin J-M, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, Astarie-Dequeker C, Lasquellec L, Arnaud B, Ducommun B, Kaplan J, Hamel CP (2000). Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nature Genet 26:207–210.PubMedGoogle Scholar
  58. 58.
    Delettre C, Lenaers G, Pelloquin L, Belenguer P, Hamel CP (2002). OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease. Mol Genet Metab 75:97–107.PubMedGoogle Scholar
  59. 59.
    De Lonlay P, Valnot I, Barrientos A, Gorbatyuk M, Tzagoloff A, Taanman JW, Benayoun E, Chretien D, Kadhom N, Lombes A, de Baulny HO, Niaudet P, Munnich, A, Rustin, P, Rotig A (2001). A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet 29: 57–60.PubMedGoogle Scholar
  60. 60.
    De Meirleir L, Seneca S, Damis E, Sepulchre B, Hoorens A, Gerlo E, Garcia Silva MT, Hernandez EM, Lissens W, Van Coster R (2003). Clinical and diagnostic characteristics of complex III deficiency due to mutations in the BCS1L gene. Am J Med Genet 121: 126–131.Google Scholar
  61. 61.
    De Meirleir L, Seneca S, Lissens W, De Clercq I, Eyskens F, Gerlo E, Smet J, Van Coster R (2004). Respiratory chain complex V deficiency due to a mutation in the assembly gene ATP12. J Med Genet 41:120–124.PubMedGoogle Scholar
  62. 62.
    Di Giovanni S, Mirabella M, Spinazzola A, Crociani P, Silvestri G, Broccolini A, Tonali P, Di Mauro S, Servidei S (2001). Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. Neurology 57:515–518.PubMedGoogle Scholar
  63. 63.
    Dimmer KS, Navoni F, Casarin A, Trevisson E, Endele S, Winterpacht A, Salviati L, Scorrano L (2008). LETM1, deleted in Wolf-Hirschhorn syndrome is required for normal mitochondrial morphology and cellular viability. Hum Mol Genet 17:201–214.PubMedGoogle Scholar
  64. 64.
    Dunning CJ, McKenzie M, Sugiana C, Lazarou M, Silke J, Connelly A, Fletcher JM, Kirby DM, Thorburn DR, Ryan MT (2007). Human CIA30 is involved in the early assembly of mitochondrial complex I and mutations in its gene cause disease, EMBO J 26:3227–3237.PubMedGoogle Scholar
  65. 65.
    Fellman V (2002). The GRACILE syndrome, a neonatal lethal metabolic disorder with iron overload. Blood Cells Mol Dis 29:4444–4450.Google Scholar
  66. 66.
    Fernandez-Moreira D, Ugalde C, Smeets R, Rodenburg RJ, Lopez-Laso E, Ruiz-Falco ML, Briones P, Martin MA, Smeitink JA, Arenas J (2007). X-linked NDUFA1 gene mutations associated with mitochondrial encephalomyopathy. Ann Neurol 61:73–83.PubMedGoogle Scholar
  67. 67.
    Fernandez-Vizarra E, Bugiani M., Goffrini P, Carrara F, Farina L, Procopio E, Donati A, Uziel G, Ferrero I, Zeviani M (2007). Impaired complex III assembly associated with BCS1L gene mutations in isolated mitochondrial encephalopathy. Hum Mol Genet 16:1241–1252.PubMedGoogle Scholar
  68. 68.
    Fernandez-Vizarra E, Berardinelli A, Valente L, Tiranti V, Zeviani M (2007). Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anemia (MLASA). J Med Genet 44:173–180.PubMedGoogle Scholar
  69. 69.
    Fernandez-Vizarra E, Tiranti V, Zeviani M (2009). Assembly of the oxidative phosphorylation system in humans: What we have learned by studying its defects. Biochim Biophys Acta. 1993: 200–211.Google Scholar
  70. 70.
    Ferreirinha F, Quattrini A, Pirozzi M, Valsecchi V, Dina G, Broccoli V, Auricchio A, Piemonte F, Tozzi G, Gaeta L, Casari G, Ballabio A, Rugarli EI (2004). Axonal degeneration in paraplegin deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J Clin Invest 113:231–242.PubMedGoogle Scholar
  71. 71.
    Fontaine B, Davoine CS, Dürr A, Paternotte C, Feki I, Weissenbach J, Hazan J, Brice A (2000). A new locus for autosomal dominant pure spastic paraplegia, on chromosome 2q24–q34. Am J Hum Genet 66:702–707.PubMedGoogle Scholar
  72. 72.
    Fontanesi F, Soto IC, Horn D, Barrientos A (2006). Assembly of mitochondrial cytochrome c-oxidase, a complicated and highly regulated cellular process. Am J Physiol Cell Physiol 291:C1129–C1147.PubMedGoogle Scholar
  73. 73.
    Frickey T, Lupas AN (2004). Phylogenetic analysis of AAA proteins. J Struct Biol 146:2–10.PubMedGoogle Scholar
  74. 74.
    Gabaldon T, Rainey D, Huynen MA (2005). Tracing the evolution of a large protein complex in the eukaryotes, NADH:ubiquinone oxidoreductase (Complex I). J Mol Biol 348: 857–870.PubMedGoogle Scholar
  75. 75.
    Galante YM, Hatefi Y (1978). Resolution of complex I and isolation of NADH dehydrogenase and an iron-sulfur protein. Methods Enzymol 53:15–21.PubMedGoogle Scholar
  76. 76.
    Gironi M, Lamperti C, Nemni R, Moggio M, Comi G, Guerini FR, Ferrante P, Canal N, Naini A, Bresolin N, DiMauro S (2004). Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency. Neurology 62:818–820.PubMedGoogle Scholar
  77. 77.
    Goto Y, Murayama K, Hirawake H, et al. (1998). Molecular genetics of 5 patients with succinate dehydrogenase deficiency [abstract]. Am J Hum Genet (suppl 63): A362.Google Scholar
  78. 78.
    Grigorieff N (1999). Structure of the respiratory NADH: ubiquinone oxidoreductase (complex I). Curr Opin Struct Biol 9:476–483.PubMedGoogle Scholar
  79. 79.
    Griparic L, van der Wel NN, Orozco IJ, Peters PJ, van der Bliek AM (2004). Loss of the intermembrane space protein Mgm1/OPA1 induces swelling and localized constrictions along the lengths of mitochondria. J Biol Chem 279:18792–18798.PubMedGoogle Scholar
  80. 80.
    Gusella JF, Tanzi RE, Bader PI, Phelan MC, Stevenson R, Hayden MR, Hofman KJ, Faryniarz AG, Gibbons K (1985). Deletion of Huntington’s disease-linked G8 (D4S10) locus in Wolf-Hirschhorn syndrome. Nature 318:75–78.PubMedGoogle Scholar
  81. 81.
    Hansen JJ, Durr A, Cournu-Rebeix I, Georgopoulos C, Ang D, Nielsen MN, Davoine CS, Brice A, Fontaine B, Gregersen N, Bross P (2002). Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am J Hum Genet 70:1328–1332.PubMedGoogle Scholar
  82. 82.
    Hattori N, Yoshino H, Tanaka M, Suzuki H, Mizuno Y (1998). Genotype in the 24-kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson disease. Genomics 49:52–58.PubMedGoogle Scholar
  83. 83.
    Haut S, Brivet M, Touati G, Rustin P, Lebon S, Garcia-Cazorla A, Saudubray J M, Boutron A, Legrand A, Slama A (2003). A deletion in the human QP-C gene causes a complex III deficiency resulting in hypoglycaemia and lactic acidosis. Hum Genet 113:118–122.PubMedGoogle Scholar
  84. 84.
    Hinson JT, Fantin VR, Schonberger J, Breivik N, Siem G, McDonough B, Sharma P, Keogh I, Godinho R, Santos F, Esparza A, Nicolau Y, Selvaag E, Cohen BH, Hoppel CL, Tranebjaerg L, Eavey RD, Seidman JG, Seidman CE (2007). Missense mutations in the BCS1L gene as a cause of the Bjornstad syndrome. N Engl J Med 356:809–819.PubMedGoogle Scholar
  85. 85.
    Hinttala R, Uusimaa J, Remes AM, Rantala H, Hassinen IE, Majamaa K (2005). Sequence analysis of nuclear genes encoding functionally important complex I subunits in children with encephalomyopathy. J Mol Med 83:786–794.PubMedGoogle Scholar
  86. 86.
    Hirst J, Carroll J, Fearnley IM, Shannon RJ, Walker JE (2003). The nuclear encoded subunits of complex I from bovine heart mitochondria. Biochim Biophys Acta 1604:135–150.PubMedGoogle Scholar
  87. 87.
    Hoefs SJ, Dieteren CE, Distelmaier F, Janssen RJ, Epplen A, Swarts HG, Forkink M, Rodenburg RJ, Nijtmans LG, Willems PH, Smeitink JA, van den Heuvel LP (2008). NDUFA2 complex I mutation leads to Leigh disease. Am J Hum Genet 82:1306–1315.PubMedGoogle Scholar
  88. 88.
    Hoogenraad N, Ward L, Ryan M (2002). Import and assembly of proteins into mitochondria of mammalian cells. Biochim Biophys Acta 1592:97–105.PubMedGoogle Scholar
  89. 89.
    Horvath R, Abicht A, Holinski-Feder E, Laner A, Gempel K, Prokisch H, Lochmuller H, Klopstock T, Jaksch M (2006). Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA). J Neurol Neurosurg Psychiatry 77:74–76.PubMedGoogle Scholar
  90. 90.
    Houstek J, Klement P, Floryk D, Antonická H, Hermanská J, Kalous M, Hansíková H, Hout’ková H, Chowdhury SK, Rosipal T, Kmoch S, Stratilová L, Zeman J (1999). A novel deficiency of mitochondrial ATPase of nuclear origin. Hum Mol Genet 8:1967–1974.PubMedGoogle Scholar
  91. 91.
    Houstek J, Pícková A, Vojtísková A, Mrácek T, Pecina P, Jesina P (2006). Mitochondrial diseases and genetic defects of ATP synthase. Biochim Biophys Acta 1757:1400–1405.PubMedGoogle Scholar
  92. 92.
    Huckriede A, Heikema A, Sjollema K, Briones P, Agsteribbe E (1995). Morphology of the mitochondria in heat shock protein 60 deficient fibroblasts from mitochondrial myopathy patients. Effects of stress conditions. Virchows Arch 427:159–165.PubMedGoogle Scholar
  93. 93.
    Hudson G, Amati-Bonneau P, Blakely EL, Stewart JD, He L, Schaefer AM, Griffiths PG, Ahlqvist K, Suomalainen A, Reynier P, McFarland R, Turnbull DM, Chinnery PF, Taylor RW (2008). Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNAdeletions: a novel disorder of mtDNA maintenance. Brain 131:329–337.PubMedGoogle Scholar
  94. 94.
    Iwata S, Lee JW, Okada K, Lee JK, Iwata M, Rasmussen B, Link TA, Ramaswamy S, Jap BK (1998). Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. Science 281:64–71.PubMedGoogle Scholar
  95. 95.
    Jacobs HT, Turnbull DM (2005). Nuclear genes and mitochondrial translation: a new class of genetic disease. Trends Genet 21:312–314.PubMedGoogle Scholar
  96. 96.
    Jaksch M, Ogilvie I, Yao J, Kortenhaus G, Bresser HG, Gerbitz KD, Shoubridge EA (2000). Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency. Hum Mol Genet 9:795–801.PubMedGoogle Scholar
  97. 97.
    Janssen RJ, Nijtmans LG, van den Heuvel LP, Smeitink JA (2006). Mitochondrial complex I: structure, function and pathology. J Inherit Metab Dis 29:499–515.PubMedGoogle Scholar
  98. 98.
    Jin H, May M, Tranebjaerg L, Kendall E, Fontan G, Jackson J, Subramony SH, Arena F, Lubs H, Smith S, Stevenson R, Schwartz C, Vetrie D (1996). A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness. Nature Genet 14:177–180.PubMedGoogle Scholar
  99. 99.
    Kim JY, Hwang JM, Ko HS, Seong MW, Park BJ, Park SS (2005). Mitochondrial DNA content is decreased in autosomal dominant optic atrophy. Neurology 64:966–972.PubMedGoogle Scholar
  100. 100.
    Kirby DM, Crawford M, Cleary MA, Dahl HH, Dennett X, Thorburn DR (1999). Respiratory chain complex I deficiency: an underdiagnosed energy generation disorder. Neurology 52:1255–1264.PubMedGoogle Scholar
  101. 101.
    Kirby DM, Salemi R, Sugiana C, Ohtake A, Parry L, Bell KM, Kirk EP, Boneh A, Taylor RW, Dahl HH, Ryan MT, Thorburn DR (2004). NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency. J Clin Invest 114:837–845.PubMedGoogle Scholar
  102. 102.
    Kirino Y, Yasukawa T, Ohta S, Akira S, Ishihara K, Watanabe K, Suzuki T (2004). Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc Natl Acad Sci U S A 101:15070–15075.PubMedGoogle Scholar
  103. 103.
    Koppen M, Metodiev MD, Casari G, Rugarli EI, Langer T (2007). Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia. Mol Cell Biol 27:758–767.PubMedGoogle Scholar
  104. 104.
    Kotarsky H, Tabasum I, Mannisto S, Heikinheimo M, Hansson S, Fellman V (2007). BCS1L is expressed in critical regions for neural development during ontogenesis in mice. Gene Expr Patterns 7:266–273.PubMedGoogle Scholar
  105. 105.
    Lagier-Tourenne C, Tazir M, López LC, Quinzii CM, Assoum M, Drouot N, Busso C, Makri S, Ali-Pacha L, Benhassine T, Anheim M, Lynch DR, Thibault C, Plewniak F, Bianchetti L, Tranchant C, Poch O, DiMauro S, Mandel JL, Barros MH, Hirano M, Koenig M (2008). ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet 82:661–672.PubMedGoogle Scholar
  106. 106.
    Lamperti C, Naini A, Hirano M, De Vivo DC, Bertini E, Servidei S, Valeriani M, Lynch D, Banwell B, Berg M, Dubrovsky T, Chiriboga C, Angelini C, Pegoraro E, DiMauro S (2003). Cerebellar ataxia and coenzyme Q10 deficiency. Neurology 60:1206–1208.PubMedGoogle Scholar
  107. 107.
    Lazarou M, Thorburn DR, Ryan MT, McKenzie M (2009). Assembly of mitochondrial complex I and defects in disease. Biochim Biophys Acta. 1793: 77–88Google Scholar
  108. 108.
    Leary SC, Kaufman BA, Pellecchia G, Guercin GH, Mattman A, Jaksch M, Shoubridge EA (2004). Human SCO1 and SCO2 have independent, cooperative functions in copper delivery to cytochrome c oxidase. Hum Mol Genet 13:1839–1848.PubMedGoogle Scholar
  109. 109.
    Leary SC, Cobine PA, Kaufman BA, Guercin GH, Mattmanm A, Palaty J, Lockitch G, Winge DR, Rustin P, Horvath P, Shoubridge EA (2007). The human cytochrome c oxidase assembly factors SCO1 and SCO2 have regulatory roles in the maintenance of cellular copper homeostasis. Cell Metab 5:6909–6920.Google Scholar
  110. 110.
    Le Ber I, Dubourg O, Benoist JF, Jardel C, Mochel F, Koenig M, Brice A, Lombès A, Dürr A (2007). Muscle coenzyme Q10 deficiencies in ataxia with oculomotor apraxia 1. Neurology 68:295–297.PubMedGoogle Scholar
  111. 111.
    Lebon S, Rodriguez D, Bridoux D, Zerrad A, Rotig A, Munnich A, Legrand A, Slama A (2007). A novel mutation in the human complex I NDUFS7 subunit associated with Leigh syndrome. Molec Genet Metab 90:379–382.PubMedGoogle Scholar
  112. 112.
    Lodi R, Tonon C, Valentino ML, Iotti S, Clementi V, Malucelli E, Barboni P, Longanesi L, Schimpf S, Wissinger B, Baruzzi A, Barbiroli B, Carelli V (2004). Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. Ann Neurol 56:719–723.PubMedGoogle Scholar
  113. 113.
    Loeffen J, Smeitink J, Triepels R, Smeets R, Schuelke M, Sengers R, Trijbels F, Hamel B, Mullaart R, van den Heuvel L (1998). The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. Am J Hum Genet 63:1598–1608.PubMedGoogle Scholar
  114. 114.
    Loeffen JL, Smeitink JA, Trijbels JM, Janssen AJ, Triepels RH, Sengers RC, van den Heuvel LP (2000). Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat 15:123–134.PubMedGoogle Scholar
  115. 115.
    Loeffen J, Elpeleg O, Smeitink J, Smeets R, Stockler-Ipsiroglu S, Mandel H, Sengers R, Trijbels F, van den Heuvel L (2001). Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann Neurol 49:195–201.PubMedGoogle Scholar
  116. 116.
    López LC, Schuelke M, Quinzii CM, Kanki T, Rodenburg RJ, Naini A, Dimauro S, Hirano M (2006). Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am J Hum Genet 79:1125–1129.PubMedGoogle Scholar
  117. 117.
    MacKenzie JA, Payne RM (2007). Mitochondrial protein import and human health and disease. Biochimica et Biophysica Acta 1772:509–523.PubMedGoogle Scholar
  118. 118.
    Magen D, Georgopoulus C, Bross P, Ang D, Segev Y, Goldsher D, Nemirovski A, Shahar E, Ravid S, Luder A, Heno B, Gershoni-Baruch R, Skorecki K, Mandel H (2008). Mitochondrial hsp60 chaperonopahty causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am J Hum Genet 83:30–42.PubMedGoogle Scholar
  119. 119.
    Martin MA, Blazquez A, Gutierrez-Solana LG, Fernandez-Moreira D, Briones P, Andreu AL, Garesse R, Campos Y, Arenas J (2005). Leigh syndrome associated with mitochondrial complex I deficiency due to a novel mutation in the NDUFS1 gene. Arch Neurol 62:659–661.PubMedGoogle Scholar
  120. 120.
    Marziliano N, Mannarino S, Nespoli L, Diegoli M, Pasotti M, Malattia C, Grasso M, Pilotto A, Porcu E, Raisaro A, Raineri C, Dore R, Maggio PP, Brega A, Arbustini E (2007). Barth syndrome associated with compound hemizygosity and heterozygosity of the TAZ and LDB3 genes. Am J Med Genet A 143A:907–915.PubMedGoogle Scholar
  121. 121.
    Massa V, Fernandez-Vizarra E, Alshahwan S, Bakhsh E, Goffrini P, Ferrero I, Mereghetti P, D’Adamo P, Gasparini P, Zeviani M (2008). Severe infantile encephalomyopathy caused by a mutation in COX6B1, a nucleus-encoded subunit of cytochrome c oxidase. Am J Hum Genet 82:1281–1289.PubMedGoogle Scholar
  122. 122.
    McKenzie M, Lazarou M, Thorburn DR, Ryan MT (2006). Mitochondrial respiratory chain supercomplexes are destabilized in Barth syndrome patients. J Mol Biol 361:462–469.PubMedGoogle Scholar
  123. 123.
    Michael S, Mindong R (2006). Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett 580:5450–5455.Google Scholar
  124. 124.
    Miller C, Saada A, Shaul N, Shabtai N, Ben-Shalom E, Shaag A, Hershkovitz E, Elpeleg O (2004). Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann Neurol 56:734–738.PubMedGoogle Scholar
  125. 125.
    Mochel F, Knight MA, Tong WH, Hernandez D, Ayyad K, Taivassalo T, Andersen PM, Singleton A, Rouault TA, Fischbeck KH, Haller RG (2008). Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes myopathy with exercise intolerance. Am J Hum Genet 82:652–660.PubMedGoogle Scholar
  126. 126.
    Mollet J, Giurgea I, Schlemmer D, Dallner G, Chretien D, Delahodde A, Bacq D, de Lonlay P, Munnich A, Rötig A (2007). Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J Clin Invest 117:765–772.PubMedGoogle Scholar
  127. 127.
    Mollet J, Delahodde A, Serre V, Chretien D, Schlemmer D, Lombes A, Boddaert N, Desguerre I, de Lonlay P, de Baulny HO, Munnich A, Rötig A (2008). CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet 82:623–630.PubMedGoogle Scholar
  128. 128.
    Mootha VK, Lepage P, Miller K, Bunkenborg J, Reich M, Hjerrild M, Delmonte T, Villeneuve A, Sladek R, Xu F, Mitchell GA, Morin C, Mann M, Hudson TJ, Robinson B, Rioux JD, Lander ES (2003). Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci U S A 100:605–610.PubMedGoogle Scholar
  129. 129.
    Musumeci O, Naini A, Slonim AE, Skavin N, Hadjigeorgiou GL, Krawiecki N, Weissman BM, Tsao CY, Mendell JR, Shanske S, De Vivo DC, Hirano M, DiMauro S (2001). Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 56:849–855.PubMedGoogle Scholar
  130. 130.
    Niemann S, Muller U (2000). Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nature Genet 26:268–270.PubMedGoogle Scholar
  131. 131.
    Nijtmans LG, Taanman JW, Muijsers AO, Speijer D, Van den Bogert C (1998). Assembly of cytochrome-c oxidase in cultured human cells. Eur J Biochem 254:389–394.PubMedGoogle Scholar
  132. 132.
    Nolden M, Ehses S, Koppen M, Bernacchia A, Rugarli EI, Langer T (2005). The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria. Cell 123:277–289.PubMedGoogle Scholar
  133. 133.
    Ogasahara S, Engel AG, Frens D, Mack D (1989). Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci U S A 86:2379–2382.PubMedGoogle Scholar
  134. 134.
    Ogilvie I, Kennaway NG, Shoubridge EA (2005). A molecular chaperone for mitochondrial complex I assembly is mutated in a progressive encephalopathy. J Clin Invest 115:2784–2792.PubMedGoogle Scholar
  135. 135.
    Oquendo CE, Antonicka H, Shoubridge EA, Reardon W, Brown GK (2004). Functional and genetic studies demonstrate that mutation in the COX15 gene can cause Leigh syndrome. J Med Genet 41:540–544.PubMedGoogle Scholar
  136. 136.
    Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P, Lenaers G (2003). Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 278:7743–7746.PubMedGoogle Scholar
  137. 137.
    Olsson A, Lind L, Thornell LE, Holmberg M (2008). Myopathy with lactic acidosis is linked to chromosome 12q23.3-24.11 and caused by an intron mutation in the ISCU gene resulting in a splicing defect. Hum Mol Genet 17:1666–1672.PubMedGoogle Scholar
  138. 138.
    Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE, Walford GA, Sugiana C, Boneh A, Chen WK, Hill DE, Vidal M, Evans JG, Thorburn DR, Carr SA, Mootha VK (2008). A mitochondrial protein compendium elucidates complex I disease biology. Cell 134:112–123.PubMedGoogle Scholar
  139. 139.
    Papadopoulou LC, Sue CM, Davidson MM, Tanji K, Nishino I, Sadlock JE, Krishna S, Walker W, Selby J, Glerum DM, Coster RV, Lyon G, Scalais E, Lebel R, Kaplan P, Shanske S, De VD, Bonilla E, Hirano M, DiMauro S, Schon EA. (1999). Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 23:333–337.PubMedGoogle Scholar
  140. 140.
    Parfait B, Chretien D, Rötig A, Marsac C, Munnich A, Rustin P (2000). Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome. Hum Genet 106:236–243.PubMedGoogle Scholar
  141. 141.
    Payne M, Yang Z, Katz BJ, Warner JEA, Weight CJ, Zhao Y, Pearson ED, Treft RL, Hillman T, Kennedy RJ, Meire FM, Zhang K (2004). Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1. Am J Ophthal 138:749–755.PubMedGoogle Scholar
  142. 142.
    Pecina P, Houstkova H, Hansikova H, Zeman J, Houstek J (2004). Genetic defects of cytochrome c oxidase assembly. Physiol Res 53 (Suppl 1):S213–223.PubMedGoogle Scholar
  143. 143.
    Pequignot MO, Dey R, Zeviani M, Tiranti V, Godinot C, Poyau A, Sue C, DiMauro S, Abitbol M, Marsac C (2001). Mutations in the SURF1 gene associated with Leigh syndrome and cytochrome c oxidase deficiency. Hum Mutat 17:374–381.PubMedGoogle Scholar
  144. 144.
    Petruzzella V, Tiranti V, Fernandez P, Ianna P, Carrozzo R, Zeviani M (1998). Identification and characterization of human cDNAs specific to BCS1, PET112, SCO1, COX15, and COX11, five genes involved in the formation and function of the mitochondrial respiratory chain. Genomics 54:494-504.PubMedGoogle Scholar
  145. 145.
    Petruzzella V, Vergari R, Puzziferri I, Boffoli D, Lamantea E, Zeviani M, Papa S (2001). A nonsense mutation in the NDUFS4 gene encoding the 18 kDa (AQDQ) subunit of complex I abolishes assembly and activity of the complex in a patient with Leigh-like syndrome. Hum Molec Genet 10:529–535.PubMedGoogle Scholar
  146. 146.
    Procaccio V, Wallace DC (2004). Late-onset Leigh syndrome in a patient with mitochondrial complex I NDUFS8 mutations. Neurology 62:1899–1901.PubMedGoogle Scholar
  147. 147.
    Quinzii CM, Kattah AG, Naini A, Akman HO, Mootha VK, DiMauro S, Hirano M (2005). Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 64:534–541.Google Scholar
  148. 148.
    Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, DiMauro S, Hirano MA (2006). Mutation in para-hydroxybenzoatepolyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet 78:345–349.PubMedGoogle Scholar
  149. 149.
    Rahman S, Brown RM, Chong WK, Wilson CJ, Brown GK (2001). A SURF1 gene mutation presenting as isolated leukodystrophy. Ann Neurol 49:797–800.PubMedGoogle Scholar
  150. 150.
    Rahman S, Hargreaves I, Clayton P, Heales S (2001). Neonatal presentation of coenzyme Q10 deficiency. J Pediatr139:456–458.PubMedGoogle Scholar
  151. 151.
    Roesch K, Hynds PJ, Varga R, Tranebjaerg L, Koehler CM (2004). The calcium-binding aspartate/glutamate carriers, citrin and aralar1, are new substrates for the DDP1/TIMM8a–TIMM13 complex. Hum Mol Genet 13:2101–2111.PubMedGoogle Scholar
  152. 152.
    Rötig A, Appelkvist EL, Geromel V, Chretien D, Kadhom N, Edery P, Lebideau M, Dallner G, Munnich A, Ernster L, Rustin P (2000). Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 356:391–395.PubMedGoogle Scholar
  153. 153.
    Rouault TA, Tong WH (2008). Iron-sulfur cluster biogenesis and human disease. Trends in Genet 24:398–407.Google Scholar
  154. 154.
    Rugarli EI, Langer T (2006). Translating m-AAA protease function in mitochondria to hereditary spastic paraplegia. Trends Mol Med12:262–269.PubMedGoogle Scholar
  155. 155.
    Saada A, Shaag A, Arnon S, Dolfin T, Miller C, Fuchs-Telem D, Lombes A, Elpeleg O (2007). Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation. J Med Genet 44:784–786.PubMedGoogle Scholar
  156. 156.
    Saada A, Edvardson S, Rapoport M, Shaag A, Amry K, Miller C, Lorberboum-Galski H, Elpeleg O (2008). C6ORF66 is an assembly factor of mitochondrial complex I. Am J Hum Genet 82:32–38.PubMedGoogle Scholar
  157. 157.
    Salviati L, Freehauf C, Sacconi S, DiMauro S, Thoma J, Tsai AC-H (2004). Novel SURF1 mutation in a child with subacute encephalopathy and without the radiological features of Leigh syndrome. Am J Med Genet 128A:195–198.PubMedGoogle Scholar
  158. 158.
    Sazanov LA, Peak-Chew SY, Fearnley IM, Walker JE (2000). Resolution of the membrane domain of bovine complex I into subcomplexes: Implications for the structural organization of the enzyme. Biochemistry 39:7229–7235.PubMedGoogle Scholar
  159. 159.
    Scheper GC, van der Klok T, van Andel RJ, van Berkel CG, Sissler M, Smet J, Muravina TI, Serkov SV, Uziel G, Bugiani M, Schiffmann R, Krägeloh-Mann I, Smeitink JA, Florentz C, Van Coster R, Pronk JC, van der Knaap MS (2007). Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 39:534–539.PubMedGoogle Scholar
  160. 160.
    Schlickum S, Moghekar A, Simpson JC, Steglich C, O’Brien RJ, Winterpacht A, Endele SU (2004). LETM1, a gene deleted in Wolf-Hirschhorn syndrome, encodes an evolutionarily conserved mitochondrial protein. Genomics 83:254–261.PubMedGoogle Scholar
  161. 161.
    Schuelke M, Smeitink J, Mariman E, Loeffen J, Plecko B, Trijbels F, Stockler-Ipsiroglu S, van den Heuvel L (1999). Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet 21:260–261.PubMedGoogle Scholar
  162. 162.
    Smeitink J, van den Heuvel L (1999). Human mitochondrial complex I in health and disease. Am J Hum Genet 64:1505–1510.PubMedGoogle Scholar
  163. 163.
    Smeitink J, van den Heuvel L, DiMauro S (2001). The genetics and pathology of oxidative phosphorylation. Nat Rev Genet 2:342–352.PubMedGoogle Scholar
  164. 164.
    Smeitink JA, Elpeleg O, Antonicka H, Diepstra H, Saada A, Smits P, Sasarman F, Vriend G, Jacob-Hirsch J, Shaag A, Rechavi G, Welling B, Horst J, Rodenburg RJ, van den Heuvel B, Shoubridge EA (2006). Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs. Am J Hum Genet 79:869–877.PubMedGoogle Scholar
  165. 165.
    Smirnova E, Griparic L, Shurland DL, van Der Bliek AM (2001). Dynamin-related protein drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell 12:2245–2256.PubMedGoogle Scholar
  166. 166.
    Sobreira C, Hirano M, Shanske S, Keller RK, Haller RG, Davidson E, Santorelli FM, Miranda AF, Bonilla E, Mojon DS, Barreira AA, King MP, DiMauro S (1997). Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology 48:1238–1243.PubMedGoogle Scholar
  167. 167.
    Sperl W, Jesina P, Zeman J, Mayr JA, Demeirleir L, VanCoster R, Pícková A, Hansíková H, Houstková H, Krejcík Z, Koch J, Smet J, Muss W, Holme E, Houstek J (2006). Deficiency of mitochondrial ATP synthase of nuclear genetic origin. Neuromuscul Disord 16:821–829.PubMedGoogle Scholar
  168. 168.
    Stiburek L, Vesela K, Hansikova H, Pecina P, Tesarova M, Cerna L, Houstek J, Zeman J (2005). Tissue-specific cytochrome c oxidase assembly defects due to mutations in SCO2 and SURF1. Biochem J 392:625–632.PubMedGoogle Scholar
  169. 169.
    Stock D, Leslie AG, Walker JE (1999). Molecular architecture of the rotary motor in ATP synthase. Science 286:1700–1705.PubMedGoogle Scholar
  170. 170.
    Tamai S, Iida H, Yokota S, Sayano T, Kiguchiya S, Ishihara N, Hayashi J, Mihara K, Oka T (2008). Characterization of the mitochondrial protein LETM1, which maintains the mitochondrial tubular shapes and interacts with the AAA-ATPase BCS1L. J Cell Sci 121:2588–2600.PubMedGoogle Scholar
  171. 171.
    Tiranti V, Hoertnagel K, Carrozzo R, Galimberti C, Munaro M, Granatiero M, Zelante L, Gasparini P, Marzella R, Rocchi M, Bayona-Bafaluy MP, Enriquez JA, Uziel G, Bertini E, Dionisi-Vici C, Franco B, Meitinger T, Zeviani M (1998), Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency, Am J Hum Genet 63:1609–1621.PubMedGoogle Scholar
  172. 172.
    Tiranti V, Galimberti C, Nijtmans L, Bovolenta S, Perini MP, Zeviani M (1999). Characterization of SURF-1 expression and Surf-1p function in normal and disease conditions. Hum Mol Genet 8:2533–2540, 1043.PubMedGoogle Scholar
  173. 173.
    Tranebjaerg L, Schwartz C, Eriksen H, Andreasson S, Ponjavic V, Dahl A, Stevenson RE, May M, Arena F, Barker D (1995). A new X linked recessive deafness syndrome with blindness, dystonia, fractures, and mental deficiency is linked to Xq22. J Med Genet 32:257–263.PubMedGoogle Scholar
  174. 174.
    Triepels RH, van den Heuvel LP, Loeffen JL, Buskens CA, Smeets RJ, Rubio GM, Budde SM, Mariman EC, Wijburg FA, Barth PG, Trijbels JM, Smeitink JA (1999). Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Ann Neurol 45:787–790.PubMedGoogle Scholar
  175. 175.
    Tsukihara T, Aoyama H, Yamashita E, Tomizaki T, Yamaguchi H, Shinzawa-Itoh K, Nakashima R, Yaono R, Yoshikawa S (1996). The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A. Science 272:1136–1144.PubMedGoogle Scholar
  176. 176.
    Ugalde C, Janssen RJRJ, Smeitink JAM, Nijtmans LGJ (2004). Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency. Hum Mol Genet 13:659–667.PubMedGoogle Scholar
  177. 177.
    Ugalde C, Vogel R, Huijbens R, van den Heuvel B, Smeitink J, Nijtmans L (2004). Human mitochondrial complex I assembles through the combination of evolutionary conserved modules: a framework to interpret complex I deficiencies. Hum Mol Genet 13:2461–2472.PubMedGoogle Scholar
  178. 178.
    Valente L, Tiranti V, Marsano RM, Malfatti E, Fernandez-Vizarra E, Donnini C, Mereghetti P, De Gioia L, Burlina A, Castellan C, Comi GP, Savasta S, Ferrero I, Zeviani M (2007). Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. Am J Hum Genet 80:44–58.PubMedGoogle Scholar
  179. 179.
    Valnot I, Osmond S, Gigarel N, Mehaye B, Amiel J, Cormier-Daire V, Munnich A, Bonnefont JP, Rustin P, Rotig A (2000). Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet 67:1104–1109.PubMedGoogle Scholar
  180. 180.
    Valnot I, von Kleist-Retzow JC, Barrientos A, Gorbatyuk M, Taanman JW, Mehaye B, Rustin P, Tzagoloff A, Munnich A, Rotig A (2000). A mutation in the human heme A:farnesyltransferase gene (COX10) causes cytochrome c oxidase deficiency. Hum Mol Genet 9:1245–1249.PubMedGoogle Scholar
  181. 181.
    Van Coster R, Seneca S, Smet J, Van Hecke R, Gerlo E, Devreese B, Van Beeumen J, Leroy JG, De Meirleir L, Lissens W (2003). Homozygous Gly555Glu mutation in the nuclear-encoded 70 kDa flavoprotein gene causes instability of the respiratory chain complex II. Am J Med Genet 120A:13–18.PubMedGoogle Scholar
  182. 182.
    van den Heuvel L, Ruitenbeek W, Smeets R, Gelman-Kohan Z, Elpeleg O, Loeffen J, Trijbels F, Mariman E, de Bruijn D, Smeitink J (1998). Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. Am J Hum Genet 62:262–268.PubMedGoogle Scholar
  183. 183.
    Van Maldergem L, Trijbels F, DiMauro S, Sindelar PJ, Musumeci O, Janssen A, Delberghe X, Martin JJ, Gillerot Y (2002). Coenzyme Q responsive Leigh’s encephalopathy in two sisters. Ann Neurol 52:750–754.PubMedGoogle Scholar
  184. 184.
    Visapää I, Fellman V, Vesa J, Dasvarma A, Hutton JL, Kumar V, Payne GS, Makarow M, Van Coster R, Taylor RW, Turnbull DM, Suomalainen A, Peltonen L (2002). GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 71:863–876.PubMedGoogle Scholar
  185. 185.
    Vogel R, Nijtmans L, Ugalde C, van den Heuvel L, Smeitink J (2004). Complex I assembly: a puzzling problem. Curr Opin Neurol 17:179–186.PubMedGoogle Scholar
  186. 186.
    Vogel R, Janssen RJ, Ugalde C, Grovenstein M, Huijbens RJ, Visch HJ, van den Heuvel LP, Willems PH, Zeviani M,. Smeitink JA, Nijtmans LG (2005). Human mitochondrial complex I assembly is mediated by NDUFAF1. FEBS J 272:5317–5326.PubMedGoogle Scholar
  187. 187.
    Vogel R, Smeitink JA, Nijtmans LG (2007). Human mitochondrial complex I assembly: a dynamic and versatile process. Biochim Biophys Acta 1767:1215–1227.PubMedGoogle Scholar
  188. 188.
    von Kleist-Retzow JC, Cormier-Daire V, de Lonlay P, Parfait B, Chretien D, Rustin P, Feingold J, Rötig A, and Munnich A (1998). A high rate (20%-30%) of parental consanguinity in cytochrome-oxidase deficiency. Am J Hum Genet 6:428–435.Google Scholar
  189. 189.
    von Kleist-Retzow JC, Yao J, Taanman JW, Chantrel K, Chretien D, Cormier-Daire V, Rotig A, Munnich A, Rustin P, Shoubridge EA (2001). Mutations in SURF1 are not specifically associated with Leigh syndrome. J Med Genet 38:109–113.Google Scholar
  190. 190.
    Wang WG, White PS, Ackerman SH (2001). Atp11p and Atp12p are assembly factors for the F(1)-ATPase in human mitochondria. J Biol Chem 2276:30773–30778.Google Scholar
  191. 191.
    Waterham HR, Koster J, van Roermund CWT, Mooyer PAW, Wanders RJA, Leonard JV (2007). A lethal defect of mitochondrial and peroxisomal fission. N Engl J Med 356:1736–1741.PubMedGoogle Scholar
  192. 192.
    Williams SL, Valnot I, Rustin P, Taanman JW (2004). Cytochrome c oxidase subassemblies in fibroblast cultures from patients carrying mutations in COX10, SCO1, or SURF1. J Biol Chem 279:7462–7469.PubMedGoogle Scholar
  193. 193.
    Wingert RA, Galloway JL, Barut B, Foott H, Fraenkel P, Axe JL, Weber GJ, Dooley K, Davidson AJ, Schmid B, Paw BH, Shaw GC, Kingsley P, Palis J, Schubert H, Chen O, Kaplan J, Zon LI (2005). Tübingen 2000 Screen Consortium. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature 436:1035–1039.PubMedGoogle Scholar
  194. 194.
    Xia D, Yu CA, Kim H, Xia JZ, Kachurin AM, Zhang L, Yu L, Deisenhofer J (1997). Crystal structure of the cytochrome bc1 complex from bovine heart mitochondria. Science 277: 60–66.PubMedGoogle Scholar
  195. 195.
    Xu F, Morin C, Mitchell G, Ackerley C, Robinson BH (2004). The role of the LRPPRC (leucine-rich pentatricopeptide repeat cassette) gene in cytochrome oxidase assembly: mutation causes lowered levels of COX (cytochrome c oxidase) I and COX III mRNA. Biochem J 382:331–336.PubMedGoogle Scholar
  196. 196.
    Zara V, Conte L, Trumpower BL (2007). Identification and characterization of cytochrome bc(1) subcomplexes in mitochondria from yeast with single and double deletions of genes encoding cytochrome bc(1) subunits. FEBS J 274:4526–4539.PubMedGoogle Scholar
  197. 197.
    Zordan MA, Cisotto P, Benna C, Agostino A, Rizzo G, Piccin A, Pegoraro M, Sandrelli F, Perini G, Tognon G, De Caro R, Peron S, Kronnie TT, Megighian A, Reggiani C, Zeviani M, Costa R (2006). Post-transcriptional silencing and functional characterization of the Drosophila melanogaster homolog of human Surf1. Genetics 172:229–241.PubMedGoogle Scholar
  198. 198.
    Züchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, Zappia M, Nelis E, Patitucci A, Senderek J, Parman Y, Evgrafov O, Jonghe PD, Takahashi Y, Tsuji S, Pericak-Vance MA, Quattrone A, Battaloglu E, Polyakov AV, Timmerman V, Schröder JM, Vance JM. (2004). Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 36:449–451.PubMedGoogle Scholar
  199. 199.
    Züchner S, Vance JM (2005). Emerging pathways for hereditary axonopathies. J Mol Med 83:935–943.PubMedGoogle Scholar
  200. 200.
    Zhu Z, Yao J, Johns T, Fu K, De BI, Macmillan C, Cuthbert AP, Newbold RF, Wang J, Chevrette M, Brown GK., Brown RM., Shoubridge EA (1998). SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 20:337–343.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Cristina Ugalde
    • 1
  • María Morán
    • 1
  • Alberto Blázquez
    • 1
  • Joaquín Arenas
    • 1
  • Miguel A. Martín
    • 1
  1. 1.Mitochondrial diseases laboratory, Research Center, “12 de Octubre”University Hospital; U723, CIBER de Enfermedades Raras (CIBERER), Instituto de Salud Carlos IIIMadridSpain

Personalised recommendations